BerGenBio ASA (OSL:BGBIO)
Norway · Delayed Price · Currency is NOK 1.168
+0.008 (0.69%)
At close: Oct 23, 2025
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 2.36M NOK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 5.41M, up 937.43% year-over-year. In the year 2024, BerGenBio ASA had annual revenue of 848.00K with 139.55% growth.
Revenue (ttm)
5.41M
Revenue Growth
+937.43%
P/S Ratio
8.36
Revenue / Employee
772.14K
Employees
13
Market Cap
45.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 848.00K | 494.00K | 139.55% |
| Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
| Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
| Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
| Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Navamedic ASA | 523.56M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| ArcticZymes Technologies ASA | 104.33M |
BerGenBio ASA News
- 8 months ago - BerGenBio ASA (STU:7BG0) Q4 2024 Earnings Call Highlights: Strategic Review and Financial ... - GuruFocus